226 related articles for article (PubMed ID: 35213716)
1. Efficacy and safety of proton pump inhibitors versus histamine-2 receptor blockers in the cardiac surgical population: insights from the PEPTIC trial.
van Diepen S; Coulson T; Wang X; Opgenorth D; Zuege DJ; Harris J; Agyemang M; Niven DJ; Bellomo R; Wright SE; Young PJ; Bagshaw SM;
Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35213716
[TBL] [Abstract][Full Text] [Related]
2. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
[TBL] [Abstract][Full Text] [Related]
3. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
[TBL] [Abstract][Full Text] [Related]
4. Stress Ulcer Prophylaxis in Cardiac Surgery: A Retrospective Cohort Study to Analyze the Effects of SUP Cessation.
Mekhail A; Young P; Mekhail AM; Tinawi G; Haran C; Clayton N; Galvin S
J Intensive Care Med; 2023 Oct; 38(10):917-921. PubMed ID: 37093762
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials.
Alshamsi F; Belley-Cote E; Cook D; Almenawer SA; Alqahtani Z; Perri D; Thabane L; Al-Omari A; Lewis K; Guyatt G; Alhazzani W
Crit Care; 2016 May; 20(1):120. PubMed ID: 27142116
[TBL] [Abstract][Full Text] [Related]
7. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
He N; Yan Y; Su S; Ge Q; Zhai S
Ann Pharmacother; 2022 Sep; 56(9):988-997. PubMed ID: 34971320
[TBL] [Abstract][Full Text] [Related]
8. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
Boyd C; Hassig T; MacLaren R
Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588
[TBL] [Abstract][Full Text] [Related]
9. Indications for the Use of Proton Pump Inhibitors for Stress Ulcer Prophylaxis and Peptic Ulcer Bleeding in Hospitalized Patients.
Clarke K; Adler N; Agrawal D; Bhakta D; Sata SS; Singh S; Gupta A; Pahwa A; Pherson E; Sun A; Volpicelli F; Cho HJ
Am J Med; 2022 Mar; 135(3):313-317. PubMed ID: 34655535
[TBL] [Abstract][Full Text] [Related]
10. Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
Barbateskovic M; Marker S; Granholm A; Anthon CT; Krag M; Jakobsen JC; Perner A; Wetterslev J; Møller MH
Intensive Care Med; 2019 Feb; 45(2):143-158. PubMed ID: 30680444
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
MacLaren R; Campbell J
Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists Likely Increase Mortality in Critical Care: An Updated Meta-Analysis.
Lee TC; Goodwin Wilson M; Lawandi A; McDonald EG
Am J Med; 2021 Mar; 134(3):e184-e188. PubMed ID: 32931766
[TBL] [Abstract][Full Text] [Related]
14. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers.
Grindlinger GA; Cairo SB; Duperre CB
J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
Reynolds PM; MacLaren R
Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
[TBL] [Abstract][Full Text] [Related]
16. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.
Toews I; George AT; Peter JV; Kirubakaran R; Fontes LES; Ezekiel JPB; Meerpohl JJ
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD008687. PubMed ID: 29862492
[TBL] [Abstract][Full Text] [Related]
17. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
Scally B; Emberson JR; Spata E; Reith C; Davies K; Halls H; Holland L; Wilson K; Bhala N; Hawkey C; Hochberg M; Hunt R; Laine L; Lanas A; Patrono C; Baigent C
Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):231-241. PubMed ID: 29475806
[TBL] [Abstract][Full Text] [Related]
18. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
[TBL] [Abstract][Full Text] [Related]
19. Histamine-2-receptor antagonist administration and gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shock.
Barletta JF
Ann Pharmacother; 2014 Oct; 48(10):1276-81. PubMed ID: 24982312
[TBL] [Abstract][Full Text] [Related]
20. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis.
Marik PE; Vasu T; Hirani A; Pachinburavan M
Crit Care Med; 2010 Nov; 38(11):2222-8. PubMed ID: 20711074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
